White & Case Advises GHO Capital on Acquisition of Envision Pharma | White & Case LLP International Law Firm, Global Law Practice
White & Case Advises GHO Capital on Acquisition of Envision Pharma

White & Case Advises GHO Capital on Acquisition of Envision Pharma

Global law firm White & Case LLP has advised GHO Capital, the European specialist investor in healthcare, on its collaboration with investment firm Ardian for the acquisition of Envision Pharma Group.

"This transaction was a great opportunity to combine our experience of advising financial sponsors with our extensive healthcare and pharmaceutical industry capabilities," said White & Case partner Ian Bagshaw, who led the Firm's deal team, "It demonstrates our ability to support clients on their most important and complex matters across our worldwide network."

Founded in 2001, Envision Pharma is a global technology and scientific communications company serving the medical affairs requirements of pharmaceutical, biotechnology, and medical device companies.

The White & Case team in London that advised on the transaction included partners Ian Bagshaw, John Cunningham, Prabhu Narasimhan and Martin Forbes, with support from associates Steven Worthington, Tom Merrifield, Craig Fagan and David Nisbet.

Press contact
For more information please speak to your local media contact.